United Capital Financial Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

United Capital Financial Advisors’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,602	Closed	-$292K	–	914
2023 Q2	$292K	Buy	+7,602	New	+$195K	﹤0.01%	775

United Capital Financial Advisors's KDNY Position: Q3 2023 in Review

United Capital Financial Advisors sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 7,602 shares — an estimated $292K sold.

United Capital Financial Advisors first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $292K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

United Capital Financial Advisors reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
United Capital Financial Advisors sold 7,602 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $292K.
United Capital Financial Advisors first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
United Capital Financial Advisors's Chinook Therapeutics, Inc. Common Stock position peaked at $292K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on United Capital Financial Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.